The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S.

Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...